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Objectives: There is little information on the changes in the pattern of occupational asthma
(OA) over time. The objective of this study was to evaluate the time trends in the incidence
and causes of immunological OA in Belgium using workers’ compensation data.
Methods: Cases of OA were identified through a retrospective review of all claims submitted by
salaried workers to the Belgian Workers’ Compensation Board from 1993 to 2002. The likeli-
hood of OA was categorized as definite, probable, or possible based upon the results of from
diagnostic procedures. Time trends were evaluated using Spearman’s rank correlation for
crude numbers of cases and through the negative binomial regression for incidence rates of
OA per industry.
Results: From a total of 1852 claims, 971 were categorized as having definite, probable, or
possible OA. There was a downward trend in the annual number of cases due to the main
causes of OA (i.e. flour, isocyanates, woods, and enzymes) and an apparent increase in cases
of latex-induced OA. The estimated average annual incidence of OA was 29.4 (95% CI:
27.6e31.3) new cases per million salaried workers during the 1993e2002 period. There was
a significant decline in the overall incidence rate of OA throughout the study period from
35.5 new cases per million salaried workers in 1993 to 25.8 in 2002.
Conclusions: These compensation-based data indicate that there has been a global downward
trend in the incidence of OA during the nineties, although the factors that determined this
reduced incidence should be further investigated.
ª 2011 Elsevier Ltd. All rights reserved.y volume in one second; HMW, high molecular weight; LMW, low molecular weight; OA, occupational
ine causing a 20% fall in FEV1; SIC, specific inhalation challenge; WCB, Workers’ Compensation Board.
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Occupational asthma in Belgium 1365Introduction In Belgium, all workers who submit a claim for OA areThere is convincing evidence that a substantial fraction
(w18%) of adult asthma is attributable to work exposures,1
although immunologically-mediated occupational asthma
(OA) is e by definition e a potentially preventable dis-
ease.2e4 Determining the burden and causes of OA is a key
step in order to implement efficient prevention strategies.
OA may result either from immunologically-mediated sensi-
tization to occupational agents (i.e. ‘hypersensitivity
induced OA’ or ‘allergic’ occupational asthma) or from
exposure(s) to high concentrations of irritant compounds
(i.e., ‘acute irritant-induced asthma’), best typified by the
‘reactive airways dysfunction syndrome’.2,4,5 Muchofwhat is
currently known about the incidence and etiological agents
of immunological OA is based upon voluntary notification
programs6e14 and medico-legal statistics or occupational
disease registers.15e18 However, there is not much informa-
tion available on the changes over time in the pattern of OA.
This information has been derived from theQuebecWorkers’
Compensation Board (1989e1999),17 the Finnish Register of
Occupational diseases (1992e2001),18 and voluntary notifi-
cation programs in the UK (1992e2001)19 and the West
Midlands (1991e2005) (Bakerly, 2008 #6154}. These data-
bases yielded some suggestion as to a decrease in incident
cases of OA in the late nineties.18,19 However, these diverse
sources of information have inherent limitations and are
difficult to compare due to differences in the diagnostic
criteria and data collection schemes.20,21
The aim of this study was to investigate the time trends
in the incidence and causes of immunological OA using
a uniform diagnostic algorithm applied to the Belgian
worker’s compensation data over the period 1993e2002.MethodsIdentification of occupational asthma
This study was based on a retrospective review of all claims
for immunological OA that were notified by salaried
workers to the Belgian Workers’ Compensation Board (WCB)
(Fonds des Maladies Professionnelles e Fonds voor de
Beroepsziekten) from January 1993 to December 2002. In
Belgium, only immunological OA2,4,5 is considered as an
occupational disease and compensated by the WCB, while
inhalation accidents are compensated by an industrial
injury insurance agency. Therefore, the few claims (nZ 83)
related to acute exposure to irritant compounds (i.e.
reactive airways dysfunction syndrome) were excluded
from this analysis; since claims for acute irritant-induced
asthma submitted to the WCB are not representative of
the incidence of this condition in the general population.
The WCB medical records were reviewed by two research
assistants who collected the information pertaining to the
demographic, occupational, and clinical characteristics of
the claimants using a standard data extraction sheet. The
study was approved by the Surveillance Committee of the
Belgian Crossroads Bank for Social Security, which is
responsible for the security and privacy protection of
electronic personal information in the social sector.requested to undergo a complete a medical evaluation by
chest physicians at the WCB office that includes: (1) an
open medical and occupational history; (2) skin-prick
testing with five common inhalant allergens, including
Dermatophagoides pteronnyssynus, cat, dog, grass pollen
mixture, and birch pollen (Stallerge`nes, Waterloo, Belgium)
in order to determine the atopic status; (3) immunological
tests including skin-prick tests and/or determination of
specific IgE antibodies (CAP Pharmacia, Uppsala, Sweden)
against occupational agents when the latter tests were
commercially available (i.e. latex, flour, enzymes, labora-
tory animals, moulds, isocyanates, formaldehyde, and acid
anhydrides); and (4) assessment of spirometry and non-
specific bronchial hyperresponsiveness to histamine.22 The
WCB’s medical experts are then allowed to refer the
claimants to specialized centers in order to perform
specific inhalation challenges (SICs) with the suspected
agent(s). The procedures of the medical evaluation
remained unchanged over the study period, with the
exception of referrals for specific inhalation challenges.
Diagnostic criteria
The likelihood of OA was categorized as: (1) definite when
the causal role of the occupational agent was supported by
a positive SIC, work-related changes on serial peak expira-
tory flow readings, or changes in the level of non-specific
bronchial hyperresponsiveness in relation to work expo-
sure23; (2) probable when IgE-mediated sensitization to the
agent (ascertained either by skin-prick testing and/or
specific IgE antibodies measurement) was associated
with functional evidence of asthma (i.e. a 15% post-
bronchodilator improvement in forced expiratory volume
in one second (FEV1) or a concentration of histamine causing
a 20% fall in FEV1 (PC20) of 8 mg/ml or less); and (3) possible
when a clinical history consistent with OA was associated
with the physiological evidence of asthma. Claims were
categorized as “indeterminate” when available data in the
medical file were insufficient to ascribe a diagnostic likeli-
hood based on these criteria. The algorithm used for
categorizing the likelihood of OA was based on a recent
meta-analysis by Beach and co-workers,24 assuming a pre-
test probability of OA of 50%, which reflects populations
evaluated in tertiary centers. These authors estimated the
positive predictive value for OA (using the SIC result as the
“reference standard”) at 77% (95% confidence interval:
50e100%) when IgE-mediated sensitization to HMW agents is
associated with non-specific bronchial hyperresponsiveness
and at 62% (95% CI: 51e73%) when the clinical history is
consistent with OA and non-specific hyperresponsiveness is
documented in the case of mixed HMW and LMW agents. For
the purpose of this analysis, claims were considered as
OA cases when assigned a definite, probable, or possible
diagnosis.
Analysis of results
Data are presented as medians with 25th and 75th percen-
tiles for numerical variables. Comparisons were made using
the Wilcoxon rank sum test for numerical variables and
1366 O. Vandenplas et al.either Chi-square or Fisher exact tests for categorical
variables.
Industries were coded using the statistical classification
of economic activities (NACE Rev1.1) of the European
Community.25 The annual numbers of salaried workers by
industries were obtained from the National Social Security
Office (Office National de la Se´curite´ Sociale e Rijksdienst
voor Sociale Zekerheid). The number of exposed workers
per occupation could not be used for estimating incidence
rates since this information was not available for the entire
study period. The 95% confidence intervals of the incidence
rates were computed using the Poisson distribution.
The time trends in the number of OA cases throughout
the studied period were evaluated using Spearman’s rank
correlation between annual case counts and calendar years
from 1993 to 2002. As proposed by McNamee and co-
workers,26 we estimated the changes in incidence of OA
cases per year (i.e. time trends) using a Poisson regression
model, implemented using the STATA v.11 Poisson proce-
dure. The dependent variable was the number of cases,
including zeros, per year. The main predictor of interest,
calendar time, was represented as a continuous variable
with a scale of years. The latter analyses estimated annual
percentage change in incidence over the time span of the
study, based on the assumption that the change was
constant from year to year. Even if this assumption is not
true, this estimate can be viewed as an approximate
measure of average change or trend.26 The Goodness-of-fit
of the Poisson regression model indicated a marked over-
dispersion for all the models, requiring the use of Negative
Binomial Regressions. The level of statistical significance
was set at a p value <0.05.
Results
Demographic and clinical data
A total of 1852 claims for OA were submitted to the WCB
during the period from 1993 to 2002. Based on their chart
review, 971 claimants were categorized as having OA,
including 355 (37%) claims with a definite, 323 (33%) with
a probable, and 293 (30%) with a possible diagnosis. Among
the claimants with definite OA, the diagnosis was docu-
mented through SIC in 311 (88%) subjects, peak expiratory
flow records in 71 (20%) subjects, both procedures in 29
(8%) subjects, and serial assessments of non-specific bron-
chial hyperresponsiveness alone in 2 (0.6%) workers.
The proportion of claims that were categorized as defi-
nite OA increased from 117/913 (13%) in 1993e1997 to 238/
939 (25%, p< 0.001) in 1998e2002. Conversely, the
proportions of claims that were assigned a probable or
possible diagnosis of OA decreased from 201/913 (22%) and
178/913 (19%) in 1993e1997 to 122/939 (13%, p< 0.001)
and 115/939 (12%, p< 0.001), respectively, in 1998e2002.
The proportion of claims with an indeterminate diagnosis
remained stable over the study period: 417 of 913 (45.7%)
for the period 1993e1997 and 464 of 939 (49.4%) for
1997e2002 (pZ 0.11).
A higher proportion of the 892 claims related to HMW
agents were classified as definite and probable OA (23.7%
and 33.5%, respectively) as compared to the 877 claimsinvolving LMW agents (16.1% and 2.7%, p< 0.001). In
contrast, claims for LMW agents were more often catego-
rized as possible OA (27.1%) and indeterminate (54.1%) as
compared to HMW agents (4.8% and 38.0%, respectively;
p< 0.001).
The demographic, occupational, and clinical character-
istics of the 971 subjects with OA are summarized in Table 1.
The median duration of exposure before the onset of work-
related asthma symptoms was 92 [95% CI: 36e192] months.
Noticeably, the median (25the75th percentiles) interval of
time elapsed between the onset of work-related asthma
symptoms and the submission of a claim to the WCB was 36
(12e76) months. This time interval did not decrease over
the years: 36 (12e82) months for claims submitted between
1993 and 1997 and 36 (12e72) months for the period
1998e2002.
Agents and industries
The distribution of agents incriminated in the development
of work-related asthma throughout the period from 1993 to
2002 is summarized in Table 2. Notably, six agents (i.e.
flour, isocyanates, latex, woods, metals, and enzymes)
accounted for 87% of all cases of OA. There was no signifi-
cant trend over the studied period in the total number of
OA cases (Spearman’s rank correlation coefficient rs:
0.450; pZ 0.192). However, analyzing the data by agents
showed a downward trend for cases of OA caused by flour,
isocyanates, wood dusts, and enzymes, which was statisti-
cally significant for flour (rs: 0.711; pZ 0.021), woods (rs:
0.857; pZ 0.002), and enzymes (rs: 0.697; pZ 0.025),
and of borderline significance for isocyanates (rs: 0.579;
pZ 0.079). In contrast, there was a significant increase in
the number of cases due to latex (rs: 0.845; pZ 0.002),
miscellaneous HMW agents (i.e. animals, plant-derived
products, moulds, and mites) (rs: 0.919; p< 0.001), and
“non-identified etiological agent” (rs: 0.711; pZ 0.021).
The industry categories and sub-categories where the
cases of OA most frequently occurred included: the
manufacture of food products and beverages (flour and
grain accounting for 312 of 322 cases, almost exclusively in
the production of grain mill products and the manufacture
of bread, pastry, and cakes); health and social work (93% of
the cases due to latex); and the manufacture of wood and
wood products (93% of the cases attributed to various wood
dusts) (Table 3). For the other industries, the pattern of
causal agents was much less specific; for instance, isocya-
nates were identified as the causal agent in 20 of 42 cases
reported in the production of chemicals (except the
production of pharmaceuticals), 18 of 21 cases in the
manufacture of rubber and plastic products; 25 of 28 cases
in the manufacture of transport equipment, 38 of 41 cases
in the maintenance and repair of motor vehicles; and 25 of
40 cases in the construction sector.
Incidence rates of occupational asthma
The annual number of claims submitted to the WBC
remained stable over the studied period, with a mean of
183 in 1993e1997 and 188 in 1998e2002 (rs: 0.103;
pZ 0.777) (Table 2). The annual number of OA cases was
Table 1 Characteristics of subjects with occupational asthma.
Characteristics Definite, probable, or
possible occupational
asthma (nZ 971)
Indeterminate claims
(nZ 881)
Gender (male) 667 (68.7) 684 (77.6)
Agea 37 (30e48) 48 (36e56)
Atopy 543 (56.3) 338 (43.5)
Pre-existing asthma 99 (10.2) 70 (8.6)
Current/ex-smokers 189/258 (19.6/26.8) 221/296 (28.1/37.6)
Duration of exposure before asthma onset, moa 92 (36e192) 132 (48e276)
Interval between onset of asthma and claim submission, moa 36 (12e76) 36 (12e84)
Other work-related disorders:
Rhinitis 609 (62.8) 312 (37.8)
Urticaria 172 (17.8) 61 (7.4)
Eczema 146 (15.1) 76 (9.2)
Medication:
Short-acting inhaled beta2-agonist 717 (74.2) 514 (62.5)
Short-acting beta2-agonist at least once a day 477 (49.4) 391 (47.5)
Inhaled corticosteroid 648 (67.0) 519 (63.0)
Long-acting inhaled beta2-agonist 215 (22.3) 206 (25.0)
Leukotriene receptor antagonist 53 (6.0) 56 (7.7)
Oral corticosteroid (continuous) 29 (3.3) 62 (8.5)
Oral H1-antihistamine 223 (25.3) 118 (16.2)
Lung function tests:
FEV1, % pred
a 86 (72e97) 75 (54e94)
FEV1< 80% pred 343 (35.5) 439 (55.5)
FEV1/FVC, %
a 75 (66e81) 72 (59e81)
Histamine PC20, mg/ml
a 1.9 (0.6e5.1) 16 (16e16)
Histamine PC20 8 mg/ml 522 (86.6) 72 (22.7)
Documented asthmab 893 (95.3) 180 (34.8)
The results are presented as numbers with percentage of available data between parentheses unless otherwise specified. FEV1: forced
expiratory volume in one second; PC20: concentration of histamine causing a 20% fall in FEV1.
a Expressed as median with 25the75th percentiles between parentheses.
b Asthmadocumentedby spirometry showinga15%post-bronchodilator improvement inFEV1orahistaminePC20 valueof8 mg/mlor less.
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induced OA was excluded from the analysis, there was
a significant decrease in the annual number of cases of OA
over time (rs: 0.782; pZ 0.008) from a mean of 88 cases
per year for the period 1993e1997 to 73 cases per year for
the period 1998e2002. Using the annual number of all
Belgian salaried workers as the denominator, the mean (95%
CI) annual incidence of OA was estimated at 29.4
(27.6e31.3) new cases per million workers over the period
1993e2002. The negative binomial regression analysis
showed a significant decline in the overall incidence of OA
among salaried workers (negative binomial regression
coefficient: 0.029; pZ 0.010) throughout the study
period.
Analysis of the time trends in incidence rates per
industry with the highest numbers of OA cases (Table 3)
revealed a significant downward trend in the manufacture
of food products and beverages (negative binomial
regression coefficient: 0.052; pZ 0.032), which mainly
resulted from a decrease in the incidence of flour-induced
OA in the production of bread, pastry, and cakes (negative
binomial regression coefficient: 0.065; pZ 0.027). There
was a decline in the incidence of OA in the retail sale ofpharmaceutical and medical goods, cosmetic and toilet
articles (negative binomial regression coefficient: 0.199;
pZ 0.039) where 13 of 15 cases of OA were due to
enzymes. The rate of OA also declined in the manufacture
of pharmaceuticals, medicinal chemicals, and botanical
products (negative binomial regression coefficient: 0.171;
pZ 0.038) where OA was attributed to various agents,
including antibiotics (nZ 10), enzymes (nZ 4), latex
(nZ 3), and non-identified agents (nZ 2). The incidence
of OA increased significantly in the health and social sector
(negative binomial regression coefficient: 0.077;
pZ 0.011) where the vast majority of cases were related
to latex.
In order to further investigate whether the observed
decrease in the annual number of OA cases due to isocya-
nates, enzymes, and wood dusts actually resulted from
declining incidence rates, we analyzed the time trends in
the rates of OA cases that were specifically caused by these
agents in the industries from where most cases originated
(as detailed above). This analysis demonstrated a down-
ward trend in the incidence of OA caused by enzymes
(negative binomial regression coefficient: 0.120;
pZ 0.049) among the exposed workforces (i.e. workers
Table 2 Distribution of causal agents, 1993e2002.
Incriminated agents Years Total
1993e2002
Spearman rank
correlation
1993 1994 1995 1996 1997 1998 1999 2000 2001 2 02 n (%)a rs (p-value)
Flour and grain 49 34 40 39 15 38 33 24 33 1 326 (33.6) 0.711 (0.021)
Isocyanates 24 17 18 31 27 22 11 11 17 2 190 (19.6) 0.579 (0.079)
Latex 12 6 13 9 16 24 21 24 17 5 167 (17.2) 0.845 (0.002)
Wood dusts 9 14 8 8 8 6 7 8 3 5 76 (7.8) 0.857 (0.002)
Enzymes 5 10 8 2 4 8 4 3 1 2 47 (4.8) 0.697 (0.025)
Metals 3 3 6 5 2 5 4 0 3 5 36 (3.7) 0.056 (0.878)
Miscellaneous LMW agents: 10 8 8 9 11 6 6 10 19 4 101 (10.4) 0.404 (0.247)
Persulphate salts 14 (1.4)
Welding 14 (1.4)
Resins, glues 11 (1.1)
Antibiotics 10 (1.0)
Aldehydes 9 (0.9)
Acrylates 5 (0.5)
Amines 4 (0.4)
Other LMW agents 34 (3.5)
Miscellaneous HMW agents: 0 0 0 0 1 1 2 4 2 3 13 (1.3) 0.919 (<0.001)
Animals 6 (0.6)
Plants 4 (0.4)
Moulds, mites 3 (0.3)
Non-identified 0 0 2 1 1 2 0 2 4 3 15 (1.5) 0.711 (0.021)
Total submitted claims 207 189 187 174 156 190 172 176 210 1 1 1852 0.103 (0.777)
Total cases of OAb 112 92 103 104 85 112 88 86 99 0 971 0.450 (0.192)
Total no. of salaried workersc 3.16 3.14 3.19 3.20 3.25 3.31 3.36 3.42 3.49 3.49
Incidence of OAd 35.5 29.3 32.5 32.2 26.2 33.9 26.2 25.2 28.4 5.8 0.029d (0.010)d
HMW: high molecular weight agents (i.e. proteins from animal and vegetal origin)29; LMW: low molecular weight (i.e. chemicals, me ls, and wood dusts).29
The causal agents were categorized in HMW agents and LMW agents is a classical way of categorizing the agents causing allergic occ ational asthma.
a Expressed as a percentage of all cases of OA.
b All cases of definite, probable, and possible OA, including those caused by latex.
c 106; data obtained from the National Social Security Office (Office National de la Se´curite´ Sociale e Rijksdienst voor Soci e
Zekerheid).
d Annual incidence rates expressed as the annual numbers of OA cases per million Belgian salaried workers. Time trends in inciden e
rates were analyzed through negative binomial regression.
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Table 3 Number of cases and estimated incidence rate of occupational asthma by industry, 1993e2002.
Nace codea Industry Total no. of
OA cases,
1993e2002c
Mean (95% CI)
annual incidence
of OAb (per
100.000 workers)
Negative binomial
regression
Coefficient (p value)
15 Manufacture of food products and beverages 322 37.0 (33.1e41.3) 0.052 (0.032)
15.61 Manufacture of grain mill products 18 142.1 (84.1e224.7) 0.145 (0.097)
15.81 Manufacture of bread, fresh pastry goods,
and cakes
288 135.2 (119.9e151.8) 0.065 (0.027)
20 Manufacture of wood, products of wood and cork
(except furniture), and articles of straw and
plaiting materials
59 49.1 (37.4e63.4) 0.042 (0.352)
24 (without 24.4) Manufacture of chemicals and chemical products 42 7.6 (5.5e10.3) 0.062 (0.277)
24.4 Manufacture of pharmaceuticals, medicinal
chemicals and botanical products
19 12.4 (7.5e19.4) 0.171 (0.038)
25 Manufacture of rubber and plastic products 21 8.6 (5.3e13.1) 0.015 (0.838)
DJ (27þ 28) Manufacture of basic metals and fabricated
metal products
46 4.6 (3.4e6.2) 0.026 (0.719)
DM (34þ 35) Manufacture of transport equipment 28 3.9 (2.6e5.6) 0.113 (0.098)
36 Manufacture of furniture 16 6.1 (3.5e10.0) 0.017 (0.843)
45 Construction 40 2.1 (1.5e2.9) 0.126 (0.083)
50 Sale, maintenance and repair of motor vehicles
and motorcycles; retail of automotive fuel
41 7.6 (5.5e10.4) 0.017 (0.752)
52.3 Retail sale of pharmaceutical and medical goods,
cosmetic and toilet articles
15 11.2 (6.3e18.5) 0.199 (0.039)
80 Education 30 0.8 (0.6e1.2) 0.007 (0.910)
85 Health and social work 139 3.9 (3.3e4.6) 0.077 (0.011)
93.02 Hairdressing and other beauty treatment 16 14.5 (8.3e23.5) 0.107 (0.237)
a Statistical classification of economic activities (NACE Rev1.1) of the European Community.25
b Computed as the mean number of OA cases reported during the period 1993e2002 in each industrial (sub)category divided by the
mean annual number of workers employed in this (sub)category during the same period.
c Data are provided for industry categories with the highest numbers of OA cases for a total of 834 among the 971 cases.
Occupational asthma in Belgium 1369employed in the manufacture of pharmaceuticals, deter-
gents, the retail sale of pharmaceuticals, and education
sector). A downward trend in the incidence of isocyanate-
induced OA was confirmed only in the construction sector
(negative binomial regression coefficient: 0.173;
pZ 0.039).Discussion
These national compensation-based data show a substantial
decline in the number of cases of OA due to the main causal
agents (i.e. flour, isocyanates, wood dusts, and enzymes)
throughout the period from 1993 to 2002. During the same
period, there was an increase in reported cases of OA
caused by natural rubber latex. However, we have recently
shown that the incidence of latex-induced OA has notice-
ably declined since 1998 in Belgium when claims are cate-
gorized by the year of asthma onset rather than the year of
claim submission.27 The observed decline in the number of
reported cases related to certain agents might have resul-
ted from the following factors: 1) changes in diagnostic
criteria or compensation legislation over time or a reduced
readiness of workers to apply for compensation; 2)
a decline in the number of workers exposed to sensitizing
agents due to changes in industrial activities; or 3) a realdecline in the incidence of new cases of OA presumably
related to a reduction in the level of exposure to sensitizing
agents at work.
In order to evaluate whether the time trends in the
crude annual numbers of cases resulted from changes in the
size of the exposed workforces, we estimated the annual
incidence rates of OA in the entire population of salaried
workers as well as in the various industrial sectors. Negative
binomial regression analysis demonstrated a significant
decline in the overall incidence of OA among the Belgian
salaried population over the period from 1993 to 2002. The
analysis also identified a significant decrease in the inci-
dence rates of OA caused by flour, enzymes, and isocya-
nates (in the construction sector). These findings indicate
that the observed downward trend in the number of cases
of OA caused by the principal agents, with the noticeable
exception of latex, is likely to result from an actual
reduction in the incidence of the disease. These data may
suggest that there has been a global reduction in the level
of exposure to certain sensitizing agents at work, leading to
a decline in the development of airway sensitization and
OA. However, some caution must be applied when inter-
preting the time trends in incidence rates of OA since
contemporary numbers of exposed workers were used as
the denominators, which may be inappropriate for
a disease with a quite long “latency”.
1370 O. Vandenplas et al.A major limitation of most medico-legal data and
voluntary notification programs results from the variability
of the diagnostic procedures used for ascertaining OA.20,21
In Belgium, all claimants are requested to complete
a standard diagnostic evaluation (i.e. clinical history,
assessment of non-specific bronchial hyperresponsiveness,
and immunological tests), although SICs and/or serial
assessments of peak expiratory flow monitoring or FEV1 at
work are not systematically performed. In order to control
for potential biases resulting from the heterogeneity in
diagnostic procedures, we a priori decided to apply
a uniform diagnostic algorithm based on the evidence
provided by a recently published meta-analysis of
diagnostic tests in OA.28 Actually, the inconsistency of
diagnostic criteria across time was confirmed by this
retrospective review; the proportion of claimants who
underwent functional assessment of the work-relatedness
of their asthma symptoms, mainly through SICs, nearly
doubled over the studied period, reaching 42% during
1998e2002. However, these changes in diagnostic proce-
dures over time are unlikely to have affected the time
trends since definite, probable, and possible cases of OA
were pooled together for these analyses. In addition, the
proportion of indeterminate claims remained unchanged
over the study period, indicating that the diagnostic shift
occurred only between the definite, probable, and possible
categories. The average incidence rate of definite, prob-
able, and possible OA estimated by applying the diagnostic
algorithm (29.4 [95% CI: 27.6e31.3] cases/yr/million sala-
ried workers) was higher than the rate derived from the
numbers of claims accepted for compensation (25.9 [95%
CI: 24.2e27.8] cases/yr/million salaried workers). Data
generated by voluntary notification schemes rely mainly
on the physician’s diagnostic opinion, since no specific
confirmatory tests are required prior to notification.14,19 In
contrast, medico-legal statistics from the Canadian
Province of Quebec and the Finnish Register of Occupa-
tional Diseases are based on the results of SICs and/or serial
measurements of peak expiratory flow rates at work in
more than 90% of compensated cases of OA.17,18
Other potential limitations inherent to compensation-
based data may have led to an underestimation of the true
incidence of OA, although it is unlikely that they may
account for the observed time trends in incident cases,
since the compensation policy and financial benefits for
compensated workers did not change over the studied
period. Indeed we analyzed the data from 1993 onwards,
because all causes of OA have been eligible for compen-
sation by the WCB since 1992. Self-employed workers
(including agriculture workers) are not covered by the
compensation scheme, although a voluntary notification
program of OA conducted in Belgium from 2000 to 2002
showed that only 7% of reported cases occurred in
self-employed workers who were not eligible for compen-
sation.12 Medico-legal statistics may also suffer from
underreporting since affected workers may not have
reported their occupational disease due to fears of adverse
consequences on their employment and income. In
Belgium, workers who qualify for compensation are entitled
to receive several types of financial compensation which
are for the most part better than those obtained from the
national health insurance. In addition, the averageincidence rate of OA for 2000e2002 that was estimated
from these compensation data (26.5 [95% CI: 23.3e30.0]
cases/yr/million salaried workers) was similar to the rate
derived from the voluntary notification program of OA for
the whole active population (21.5 [95% CI: 18.9e24.3]).
The temporal pattern of compensation claims may also
be influenced by an increased awareness of certain causes
of OA among the general and medical communities. This is
best exemplified by the observed increase in reported cases
of latex-induced OA while the true incidence of the disease
was already declining.27 These findings outline that
compensation-based data provide useful information on
time trends, but may be misleading when they are inter-
preted using the year of claim submission.
Because of the heterogeneity in legislation, diagnostic
approaches, disease attribution criteria, and data collec-
tion schemes, information from different countries is
difficult to compare. Nevertheless, our findings are consis-
tent with the overall downward trend in OA cases reported
by the Surveillance of Work-related and Occupational
Respiratory Disease (SWORD) program based on voluntary
notification by chest and occupational physicians in the
UK.19 The SWORD data showed a 20% decrease in the mean
annual number of reported cases from 703 in 1992e1995 to
559 in 1996e2001. This decline involved various LMW agents
(i.e. isocyanates, glutaraldehyde, drugs, metallic
compounds, welding fumes, colophony, and epoxy resins)
and a few HMW agents (i.e. flour and laboratory animals).19
This downward trend in reported cases of OA has been
further confirmed over the period from 1993 to 2008 while
adjusting for the tendency of participating physicians to
under-report cases over time (i.e. “reporter fatigue”
bias)26 (http://www.hse.gov.uk/statistics/causdis/asthma.
htm, accessed September 20th 2010). The data from the
Finnish Register of Occupational Diseases between 1986 and
2002 indicated that the number of OA cases increased from
1986 to 1995, decreased markedly between 1995 and 1998,
and remained stable thereafter.18 This downward trend was
attributed to a decrease in cases due to organic agents (i.e.
cow dander, flour, grain, and storage mites), which could
be related to a decrease in agricultural activities after 1995
and improvements in dairy farming processes. However, OA
due to LMW chemicals, especially isocyanates and formal-
dehyde, also decreased substantially during the same
period. In Finland, a downward trend in the overall inci-
dence of OA might have been obscured by a sharp increase
in OA due to various moulds occurring mostly among
employees working in water-damaged buildings. Medico-
legal statistics from Quebec revealed a stable number of
compensated cases of OA between 1989 and 1999, although
there has been a clear decrease in OA due to isocyanates
and drugs.17 Most of these data sources also identified
a marked increase in reported cases of latex-induced OA
during the late nineties.17e19
In conclusion, these compensation-based data provide
further evidence supporting an overall decline in the inci-
dence of OA throughout the nineties. It should be verified
whether or not this downward trend persisted in subse-
quent years. The factors that determined this reduced
incidence in OA should be further investigated since this
may have substantial implications for the implementation
of prevention policies.
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